David Rescott
Stock Analyst at Baird
(2.21)
# 1,468
Out of 4,414 analysts
40
Total ratings
40.54%
Success rate
-2.04%
Average return
Main Sectors:
Top Industries:
9 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Outperform | $79 → $84 | $72.03 | +16.62% | 3 | Apr 25, 2024 | |
| PEN Penumbra | Maintains: Buy | $300 → $290 | $206.06 | +40.74% | 13 | Feb 23, 2024 | |
| AXNX Axonics | Downgrades: Hold | $73 → $71 | $67.11 | +5.80% | 8 | Jan 16, 2024 | |
| IRTC iRhythm Technologies | Maintains: Buy | $115 → $133 | $110.88 | +19.95% | 6 | Dec 22, 2023 | |
| SIBN SI-BONE | Maintains: Buy | $25 → $26 | $14.61 | +77.96% | 6 | Dec 22, 2023 | |
| LIVN LivaNova | Maintains: Outperform | $56 → $62 | $62.92 | -1.46% | 1 | Jul 27, 2023 | |
| EW Edwards Lifesciences | Initiates: Outperform | $107 | $85.06 | +25.79% | 1 | Jul 19, 2023 | |
| MDT Medtronic | Initiates: Neutral | $90 | $80.92 | +11.22% | 1 | Jul 19, 2023 | |
| NARI Inari Medical | Initiates: Outperform | $79 | $41.99 | +88.14% | 1 | Jul 19, 2023 |
Boston Scientific
Apr 25, 2024
Maintains: Outperform
Price Target: $79 → $84
Current: $72.03
Upside: +16.62%
Penumbra
Feb 23, 2024
Maintains: Buy
Price Target: $300 → $290
Current: $206.06
Upside: +40.74%
Axonics
Jan 16, 2024
Downgrades: Hold
Price Target: $73 → $71
Current: $67.11
Upside: +5.80%
iRhythm Technologies
Dec 22, 2023
Maintains: Buy
Price Target: $115 → $133
Current: $110.88
Upside: +19.95%
SI-BONE
Dec 22, 2023
Maintains: Buy
Price Target: $25 → $26
Current: $14.61
Upside: +77.96%
LivaNova
Jul 27, 2023
Maintains: Outperform
Price Target: $56 → $62
Current: $62.92
Upside: -1.46%
Edwards Lifesciences
Jul 19, 2023
Initiates: Outperform
Price Target: $107
Current: $85.06
Upside: +25.79%
Medtronic
Jul 19, 2023
Initiates: Neutral
Price Target: $90
Current: $80.92
Upside: +11.22%
Inari Medical
Jul 19, 2023
Initiates: Outperform
Price Target: $79
Current: $41.99
Upside: +88.14%